alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 1 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strahlendorf, J | 1 |
Box, C | 1 |
Attridge, J | 1 |
Diertien, J | 1 |
Finckbone, V | 1 |
Henne, WM | 1 |
Medina, MS | 1 |
Miles, R | 1 |
Oomman, S | 1 |
Schneider, M | 1 |
Singh, H | 1 |
Veliyaparambil, M | 1 |
Strahlendorf, H | 1 |
1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Electron Transport Chain Deficiencies, Mitochondrial
Article | Year |
---|---|
AMPA-induced dark cell degeneration of cerebellar Purkinje neurons involves activation of caspases and apparent mitochondrial dysfunction.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Animals, Newborn; bcl-2-Associate | 2003 |